El gigante GSK despierta del letargo y avanza en tres vacunas del Covid-19 | Compañías elpais.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from elpais.com Daily Mail and Mail on Sunday newspapers.
consensus among member states. The European Commission
said it would begin discussions on waivers but Germany, home to BioNTech, the firm that created the vaccine being marketed by Pfizer, said it
opposed a waiver because “the protection of the intellectual property is a source of innovation and must remain so”.
However, the Indian government has taken a different line domestically: At a hearing in India’s Supreme Court this month, the court asked the government whether it intended to issue any compulsory licenses to companies to manufacture drugs like remdesivir that are being used for Covid-19 treatment.
The government reportedly
Read more about Patent waver for Covid vaccine without tech transfer won t speed up supply on Business Standard. Intellectual property rights (IPR) on drugs and vaccine formulae give creators an exclusive right over inventions for a certain period of time, and prevent pharmaceutical companies from making it.
US should pledge to create partnerships for cost-sharing, co-investment to end Covid vaccine crisis
Top Searches US should pledge to create partnerships for cost-sharing, co-investment to end Covid vaccine crisis
Rupali Mukherjee / TNN / May 17, 2021, 22:36 IST
FacebookTwitterLinkedinEMail
Representative image
MUMBAI: Pressure is mounting on rich nations, like the US to urgently address the global Covid-19 vaccine crisis, and worldwide inequities in availability of vaccines. American leadership is required to ensure universal global access to high-quality and safe vaccines, leaders across internationally-reputed organizations said.
The US should support rapid vaccine distribution and administration, and build a sustainable global network of vaccine manufacturing capacity, they said.